Last year the company failed an attempt to sell its pathology business to raise $100 million. At the same time,it suffered heavy losses. Now they want to issue new subordinated notes. Does it ring the bell?
- Forums
- ASX - By Stock
- Ann: Healthscope Notes II - Interest Rate
HLN
healthscope notes limited
Last year the company failed an attempt to sell its pathology...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)